Home/Filings/4/0001802768-24-000049
4//SEC Filing

Lloyd George W. 4

Accession 0001802768-24-000049

CIK 0001802768other

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 7:19 PM ET

Size

12.3 KB

Accession

0001802768-24-000049

Insider Transaction Report

Form 4
Period: 2024-08-12
Lloyd George W.
EVP, Investments & CLO
Transactions
  • Gift

    LP interests in RPI US Partners 2019, LP

    2024-08-127,9200 total
    Class A Ordinary Shares (79,200 underlying)
Holdings
  • LP interests in RPI US Partners 2019, LP

    (indirect: By LLC)
    Exercise: $0.00Class A Ordinary Shares (1,387,340 underlying)
    138,734
  • LP interests in RPI US Partners 2019, LP

    (indirect: By LLC)
    Exercise: $0.00Class A Ordinary Shares (986,450 underlying)
    98,645
  • LP interests in RPI US Partners 2019, LP

    (indirect: By LLC)
    Exercise: $0.00Class A Ordinary Shares (1,626,800 underlying)
    162,680
  • LP interests in RPI US Partners 2019, LP

    (indirect: By LLC)
    Exercise: $0.00Class A Ordinary Shares (81,730 underlying)
    8,173
Footnotes (3)
  • [F1]No limited partnership interests in RPI US Partners 2019, LP ("RPI US LP") are being exchanged by the Reporting Person. Each limited partnership interest in RPI US LP ("RPI US LP Interest") may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with an exchange.
  • [F2]The Reporting Person made a charitable donation of RPI US LP Interests. No Class A Ordinary Shares or RPI US LP Interests were sold.
  • [F3]Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

Issuer

Royalty Pharma plc

CIK 0001802768

Entity typeother

Related Parties

1
  • filerCIK 0001814899

Filing Metadata

Form type
4
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 7:19 PM ET
Size
12.3 KB